183 related articles for article (PubMed ID: 37741887)
1. Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer.
Qian B; Liu Q; Wang C; Lu S; Ke S; Yin B; Li X; Yu H; Wu Y; Ma Y
Sci Rep; 2023 Sep; 13(1):15919. PubMed ID: 37741887
[TBL] [Abstract][Full Text] [Related]
2. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 network as a prognostic biomarker in gastric cancer.
Li P; Ji W; Wei Z; Wang X; Qiao G; Gao C; Wang Y; Qi F
Hereditas; 2022 Nov; 159(1):43. PubMed ID: 36447214
[TBL] [Abstract][Full Text] [Related]
5. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer.
Wang B; Shen W; Yan L; Li X; Zhang L; Zhao S; Jin X
Ann Med; 2023; 55(2):2244515. PubMed ID: 37603701
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
Liu Q; Zhao H; Guo Y; Zhang K; Shang F; Liu T
J Healthc Eng; 2022; 2022():7904982. PubMed ID: 36105715
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma.
Zhang X; Zhang D; Bu X; Zhang X; Cui L
BMC Bioinformatics; 2022 Nov; 23(1):479. PubMed ID: 36376850
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
9. Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression.
Wu X; Wang Y; Chen C; Xue Y; Zheng S; Cai L
Genet Res (Camb); 2022; 2022():5671562. PubMed ID: 35903462
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA Network to Predict Prognosis for Pancreatic Cancer.
Li L; Zou W; Xiao Z; Deng Z; Liu R
Comb Chem High Throughput Screen; 2023; 26(13):2358-2371. PubMed ID: 36918789
[TBL] [Abstract][Full Text] [Related]
11. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
15. Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4
Gu J; Zhang J; Huang W; Tao T; Huang Y; Yang L; Yang J; Fan Y; Wang H
Ann Transl Med; 2020 Mar; 8(6):279. PubMed ID: 32355723
[TBL] [Abstract][Full Text] [Related]
16. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
17. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
Deng B; Wang M; Liu Z
Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
[TBL] [Abstract][Full Text] [Related]
18. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Jia Y; Shen M; Zhou Y; Liu H
Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
20. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Wang B; Chen L; Li Q; Zhou J; Jin W
Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
